Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Prostate cancer evaluation using PET quantification in 68Ga-PSMA-11 PET/MR with attenuation correction of bones as a fifth compartment.

Domachevsky L, Goldberg N, Gorenberg M, Bernstine H, Groshar D, Catalano OA.

Quant Imaging Med Surg. 2020 Jan;10(1):40-47. doi: 10.21037/qims.2019.11.19.

2.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.

Ferrone C, Goyal L, Qadan M, Gervais D, Sahani DV, Zhu AX, Hong TS, Blaszkowsky LS, Tanabe KK, Vangel M, Amorim BJ, Wo JY, Mahmood U, Pandharipande PV, Catana C, Duenas VP, Collazo YQ, Canamaque LG, Domachevsky L, Bernstine HH, Groshar D, Shih TT, Li Y, Herrmann K, Umutlu L, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Dec 11. doi: 10.1007/s00259-019-04558-3. [Epub ahead of print]

PMID:
31705172
3.

The Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Diagnosis of Postoperative Hardware-Related Spinal Infections.

Frenkel Rutenberg T, Baruch Y, Ohana N, Bernstine H, Amitai A, Cohen N, Domachevsky L, Shemesh S.

Isr Med Assoc J. 2019 Aug;21(8):532-537.

4.

Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study.

Domachevsky L, Bernstine H, Goldberg N, Nidam M, Catalano OA, Groshar D.

Eur Radiol. 2020 Jan;30(1):328-336. doi: 10.1007/s00330-019-06353-y. Epub 2019 Jul 22.

PMID:
31332559
5.

The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas.

Khafif A, Masalha M, Landsberg R, Domachevsky L, Bernstine H, Groshar D, Azoulay O, Lockman Y.

Eur Arch Otorhinolaryngol. 2019 May;276(5):1509-1516. doi: 10.1007/s00405-019-05301-2. Epub 2019 Mar 16.

PMID:
30877424
6.

FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.

Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, Gurion R, Groshar D, Raanani P, Gafter-Gvili A.

Hematol Oncol. 2019 Apr;37(2):168-175. doi: 10.1002/hon.2578. Epub 2019 Mar 18.

PMID:
30734341
7.

Clinical Implications of Incidental Sinonasal Positive FDG Uptake on PET-CT.

Tzelnick S, Bernstine H, Domachevsky L, Soudry E.

Otolaryngol Head Neck Surg. 2019 Apr;160(4):729-733. doi: 10.1177/0194599818821862. Epub 2019 Jan 1.

PMID:
30598053
8.

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study.

Domachevsky L, Kashtan H, Brenner B, Nidam M, Morgenstern S, Kundel Y, Groshar D, Bernstine H.

Medicine (Baltimore). 2018 Dec;97(49):e13412. doi: 10.1097/MD.0000000000013412.

9.

Early PET-CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study.

Moore A, Ulitsky O, Ben-Aharon I, Perl G, Kundel Y, Sarfaty M, Lewin R, Domachevsky L, Bernstine H, Groshar D, Wasserberg N, Kashtan H, Gordon N, Sulkes A, Brenner B.

Cancer Med. 2018 Nov;7(11):5470-5477. doi: 10.1002/cam4.1818. Epub 2018 Oct 22.

10.

Failure to identify sentinel lymph nodes for malignant melanoma - Outcome after over 10 years median follow up.

Zlotnik O, Bernstine H, Domachevsky L, Gutman H.

Eur J Surg Oncol. 2019 Feb;45(2):231-234. doi: 10.1016/j.ejso.2018.09.010. Epub 2018 Oct 16.

PMID:
30343996
11.

Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma.

Gurion R, Bernstine H, Domachevsky L, Michelson C, Raanani P, Vidal L, Shochat T, Gafter-Gvili A.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):687-691. doi: 10.1016/j.clml.2018.06.022. Epub 2018 Jun 27.

PMID:
30017596
12.

Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR.

Stein D, Goldberg N, Domachevsky L, Bernstine H, Nidam M, Abadi-Korek I, Guindy M, Sosna J, Groshar D.

Clin Radiol. 2018 Sep;73(9):832.e17-832.e22. doi: 10.1016/j.crad.2018.04.012. Epub 2018 May 30.

PMID:
29859634
13.

Quantitative characterisation of clinically significant intra-prostatic cancer by prostate-specific membrane antigen (PSMA) expression and cell density on PSMA-11.

Domachevsky L, Goldberg N, Bernstine H, Nidam M, Groshar D.

Eur Radiol. 2018 Dec;28(12):5275-5283. doi: 10.1007/s00330-018-5484-1. Epub 2018 May 30.

PMID:
29846803
14.

18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).

Bernstine H, Domachevsky L, Nidam M, Goldberg N, Abadi-Korek I, Shpilberg O, Groshar D.

Medicine (Baltimore). 2018 Apr;97(16):e0490. doi: 10.1097/MD.0000000000010490.

15.

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability.

Domachevsky L, Bernstine H, Nidam M, Stein D, Goldberg N, Stern D, Abadi-Korek I, Groshar D.

Contrast Media Mol Imaging. 2017 May 30;2017:8639731. doi: 10.1155/2017/8639731. eCollection 2017.

16.

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.

Domachevsky L, Leibovitzh H, Avni-Biron I, Lichtenstein L, Goldberg N, Nidam M, Groshar D, Bernstine H, Ben-Bassat O.

Contrast Media Mol Imaging. 2017 Sep 19;2017:7167292. doi: 10.1155/2017/7167292. eCollection 2017.

17.

Early 68GA-PSMA PET/MRI acquisition: assessment of lesion detectability and PET metrics in patients with prostate cancer undergoing same-day late PET/CT.

Domachevsky L, Bernstine H, Goldberg N, Nidam M, Stern D, Sosna J, Groshar D.

Clin Radiol. 2017 Nov;72(11):944-950. doi: 10.1016/j.crad.2017.06.116. Epub 2017 Jul 14.

PMID:
28716214
18.

[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER].

Noroheimer S, Ozalvo R, Abramovich A, Fenig E, Domachevsky L, Yakimov M, Baniel J, Yossepowitch O, Kedar D, Neiman V, Rosenbaum E, Margel D.

Harefuah. 2017 Jun;156(6):349-352. Hebrew. No abstract available.

PMID:
28661109
19.

Motion-robust parameter estimation in abdominal diffusion-weighted MRI by simultaneous image registration and model estimation.

Kurugol S, Freiman M, Afacan O, Domachevsky L, Perez-Rossello JM, Callahan MJ, Warfield SK.

Med Image Anal. 2017 Jul;39:124-132. doi: 10.1016/j.media.2017.04.006. Epub 2017 May 3.

20.

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT.

Groshar D, Bernstine H, Goldberg N, Nidam M, Stein D, Abadi-Korek I, Domachevsky L.

Cancer Imaging. 2017 Apr 5;17(1):11. doi: 10.1186/s40644-017-0113-9.

21.

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer.

McKay RR, Werner L, Mostaghel EA, Lis R, Voznesensky O, Zhang Z, Marck BT, Matsumoto AM, Domachevsky L, Zukotynski KA, Bhasin M, Bubley GJ, Montgomery B, Kantoff PW, Balk SP, Taplin ME.

Clin Cancer Res. 2017 Feb 15;23(4):935-945. doi: 10.1158/1078-0432.CCR-16-0987. Epub 2016 Sep 28. Erratum in: Clin Cancer Res. 2017 Jul 15;23 (14 ):3970.

22.

The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.

Zer A, Domachevsky L, Rapson Y, Nidam M, Flex D, Allen AM, Stemmer SM, Groshar D, Bernstine H.

Eur Radiol. 2016 Sep;26(9):3155-61. doi: 10.1007/s00330-015-4132-2. Epub 2015 Dec 18.

PMID:
26685851
23.

Motion Compensated Abdominal Diffusion Weighted MRI by Simultaneous Image Registration and Model Estimation (SIR-ME).

Kurugol S, Freiman M, Afacan O, Domachevsky L, Perez-Rossello JM, Callahan MJ, Warfield SK.

Med Image Comput Comput Assist Interv. 2015;9351:501-9. doi: 10.1007/978-3-319-24574-4_60.

24.

Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.

Domachevsky L, Groshar D, Galili R, Saute M, Bernstine H.

Eur Radiol. 2015 Nov;25(11):3361-7. doi: 10.1007/s00330-015-3754-8. Epub 2015 May 1.

PMID:
25929940
25.

Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings.

Domachevsky L, Jacene HA, Sakellis CG, Kim CK.

PET Clin. 2014 Apr;9(2):217-35. doi: 10.1016/j.cpet.2013.10.005. Epub 2013 Dec 10. Review.

PMID:
25030284
26.

Hyperbaric oxygen-induced seizures cause a transient decrement in cognitive function.

Domachevsky L, Rachmany L, Barak Y, Rubovitch V, Abramovich A, Pick CG.

Neuroscience. 2013 Sep 5;247:328-34. doi: 10.1016/j.neuroscience.2013.05.052. Epub 2013 Jun 1.

PMID:
23732232
27.

MRI findings after hyperbaric oxygen-induced seizures.

Domachevsky L, Pick CG, Peled N, Gomori JM, Abramovich A, Tempel-Brami C.

Epilepsy Res. 2013 Jul;105(1-2):62-8. doi: 10.1016/j.eplepsyres.2013.01.008. Epub 2013 Jan 26.

PMID:
23357721
28.

Do hyperbaric oxygen-induced seizures cause brain damage?

Domachevsky L, Pick CG, Arieli Y, Krinsky N, Abramovich A, Eynan M.

Epilepsy Res. 2012 Jun;100(1-2):37-41. doi: 10.1016/j.eplepsyres.2012.01.004. Epub 2012 Jan 30.

PMID:
22293507
29.

Image quality in obese patients undergoing 256-row computed tomography coronary angiography.

Segev OL, Gaspar T, Halon DA, Peled N, Domachevsky L, Lewis BS, Rubinshtein R.

Int J Cardiovasc Imaging. 2012 Mar;28(3):633-9. doi: 10.1007/s10554-011-9848-8. Epub 2011 Mar 19.

PMID:
21424151
30.

Sonography of multifocal Brucella orchitis.

Domachevsky L, Peled N, Barzilai M.

Ultraschall Med. 2008 Dec;29 Suppl 5:275-6. doi: 10.1055/s-2008-1027194. Epub 2008 Dec 12. No abstract available.

PMID:
19085749
31.

Hyperbaric oxygen in the treatment of sudden deafness.

Domachevsky L, Keynan Y, Shupak A, Adir Y.

Eur Arch Otorhinolaryngol. 2007 Aug;264(8):951-3. Epub 2007 Mar 15.

PMID:
17361409
32.

Proteinuria on dipstick urine analysis after sexual intercourse.

Domachevsky L, Grupper M, Shochat T, Adir Y.

BJU Int. 2006 Jan;97(1):146-8.

33.

Inner ear decompression sickness and mal de debarquement.

Tal D, Domachevsky L, Bar R, Adir Y, Shupak A.

Otol Neurotol. 2005 Nov;26(6):1204-7.

PMID:
16272943
34.

Hyperbaric oxygen in the treatment of carbon monoxide poisoning.

Domachevsky L, Adir Y, Grupper M, Keynan Y, Bentur Y.

Clin Toxicol (Phila). 2005;43(3):181-8. Review.

PMID:
15902792
35.

Transient osteoporosis associated with hyperhomocystinemia: a possible role for hyperbaric oxygen therapy.

Domachevsky L, Keynan Y, Militianu D, Goldenberg I, Adir Y.

Undersea Hyperb Med. 2004 Fall;31(3):275-9.

PMID:
15568414
36.

Swimming-induced pulmonary edema: clinical presentation and serial lung function.

Adir Y, Shupak A, Gil A, Peled N, Keynan Y, Domachevsky L, Weiler-Ravell D.

Chest. 2004 Aug;126(2):394-9.

PMID:
15302723

Supplemental Content

Loading ...
Support Center